Literature DB >> 20645403

Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.

Ralf Reilmann1, Stefan Bohlen, Thomas Klopstock, Andreas Bender, Adolf Weindl, Philipp Saemann, Dorothee P Auer, E Bernd Ringelstein, Herwig W Lange.   

Abstract

Motor symptoms in Huntington's Disease (HD) are commonly assessed by the Unified Huntington's Disease Rating Scale-Total Motor Score (UHDRS-TMS). However, the UHDRS-TMS is limited by interrater variability, its categorical nature, and insensitivity in premanifest subjects. More objective and quantitative measures of motor phenotype may complement the use of the UHDRS-TMS as outcome measure and increase the power and sensitivity of clinical trials. Deficits in tongue protrusion are well acknowledged in HD and constitute a subitem of the UHDRS-TMS. We, therefore, investigated whether objective and quantitative assessment of tongue protrusion forces (TPF) provides measures that (1) correlate to the severity of motor phenotype detected in the UHDRS-TMS in symptomatic HD, (2) detect a motor phenotype in premanifest HD gene-carriers, and (3) exhibit a correlation to the genotype as assessed by a disease burden score (based on CAG-repeat length and age). Using a precalibrated force transducer, the ability of premanifest gene carriers (n = 15) and subjects with symptomatic HD (n = 20) to generate and maintain isometric TPF at three target force levels (0.25, 0.5, and 1.0 N) was assessed and compared with age-matched controls (n = 20) in a cross-sectional study. Measures of variability of TPF and tongue contact time distinguished controls, premanifest, and symptomatic HD groups and correlated to the UHDRS-TMS and disease burden score, suggesting a strong genotype-phenotype correlation. Group distinction was most reliable at the lowest target force level. We conclude that assessment of TPF may be a useful objective and quantitative marker of motor dysfunction in premanifest and symptomatic HD.

Entities:  

Mesh:

Year:  2010        PMID: 20645403     DOI: 10.1002/mds.23243

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.

Authors:  Paul G Unschuld; Suresh E Joel; Xinyang Liu; Megan Shanahan; Russell L Margolis; Kevin M Biglan; Susan S Bassett; David J Schretlen; Graham W Redgrave; Peter C M van Zijl; James J Pekar; Christopher A Ross
Journal:  Neurosci Lett       Date:  2012-03-07       Impact factor: 3.046

2.  Magnetization transfer imaging in premanifest and manifest Huntington disease.

Authors:  S J A van den Bogaard; E M Dumas; J Milles; R Reilmann; J C Stout; D Craufurd; M A van Buchem; J van der Grond; R A C Roos
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

3.  Instrumented Assessment of Oral Motor Function in Healthy Subjects and People with Systemic Sclerosis.

Authors:  Chiara Vitali; Cinzia Baldanzi; Francesca Polini; Angelo Montesano; Paola Ammenti; Davide Cattaneo
Journal:  Dysphagia       Date:  2015-02-17       Impact factor: 3.438

4.  Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.

Authors:  Rachael I Scahill; Nicola Z Hobbs; Miranda J Say; Natalie Bechtel; Susie M D Henley; Harpreet Hyare; Douglas R Langbehn; Rebecca Jones; Blair R Leavitt; Raymund A C Roos; Alexandra Durr; Hans Johnson; Stéphane Lehéricy; David Craufurd; Christopher Kennard; Stephen L Hicks; Julie C Stout; Ralf Reilmann; Sarah J Tabrizi
Journal:  Hum Brain Mapp       Date:  2011-11-18       Impact factor: 5.038

5.  Torque variability of the plantar flexors in people with Huntington's disease.

Authors:  Mitchell Turner; Alvaro Reyes; Tim Rankin; Danielle Bartlett; Gabriel Trajano; Tim Pulverenti; Travis Cruickshank
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

6.  Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington's Disease.

Authors:  Lucy M Collins; Faye Begeti; Francesca Panin; Alpar S Lazar; Travis Cruickshank; Mel Ziman; Sarah L Mason; Roger A Barker
Journal:  PLoS Curr       Date:  2015-09-08

7.  Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.

Authors:  Lora Minkova; Sarah Gregory; Rachael I Scahill; Ahmed Abdulkadir; Christoph P Kaller; Jessica Peter; Jeffrey D Long; Julie C Stout; Ralf Reilmann; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel
Journal:  Neuroimage Clin       Date:  2017-10-25       Impact factor: 4.881

8.  Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study.

Authors:  Florian Holtbernd; Michael Deppe; Rainald Bachmann; Siawoosh Mohammadi; Erich B Ringelstein; Ralf Reilmann
Journal:  BMC Neurol       Date:  2015-10-08       Impact factor: 2.474

9.  Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues.

Authors:  Jessica Despard; Anne-Marie Ternes; Bleydy Dimech-Betancourt; Govinda Poudel; Andrew Churchyard; Nellie Georgiou-Karistianis
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

10.  Behavioral testing of minipigs transgenic for the Huntington gene-A three-year observational study.

Authors:  Verena Schuldenzucker; Robin Schubert; Lisa M Muratori; Frauke Freisfeld; Lorena Rieke; Tamara Matheis; Sarah Schramke; Jan Motlik; Nicole Kemper; Ute Radespiel; Ralf Reilmann
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.